| Fiscal Period | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Period End Date | Mar 26 | Mar 25 | Mar 24 | Mar 23 |
| Total Operating Expense | 7,656.00 | 6,790.00 | 6,014.00 | 5,741.74 |
| Other Net | 296.00 | 2.00 | 0.00 | 4.84 |
| Diluted Weighted Average Shares | 26.54 | 26.55 | 26.55 | 26.55 |
| Depreciation/ Amortization | 463.00 | 402.00 | 378.00 | 343.18 |
| Operating Income | 2,904.00 | 2,570.00 | 1,831.00 | 2,025.77 |
| Net Income | 2,568.00 | 2,191.00 | 1,600.00 | 1,823.38 |
| Income Availableto Com Excl Extra Ord | 2,568.00 | 2,191.00 | 1,600.00 | 1,823.38 |
| Other Operating Expenses Total | 1,584.00 | - | - | - |
| Net Income Before Taxes | 3,388.00 | 2,916.00 | 2,163.00 | 2,368.63 |
| Net Income After Taxes | 2,568.00 | 2,191.00 | 1,600.00 | 1,823.38 |
| Income Availableto Com Incl Extra Ord | 2,568.00 | 2,191.00 | 1,600.00 | 1,823.38 |
| Costof Revenue Total | 4,093.00 | 4,348.00 | 3,759.00 | 3,688.79 |
| Gross Profit | 6,467.00 | 5,012.00 | 4,086.00 | 4,078.72 |
| Interest Inc( Exp) Net- Non- Op Total | 188.00 | 348.00 | 336.00 | 339.15 |
| Unusual Expense( Income) | 74.00 | - | - | - |
| Diluted Net Income | 2,568.00 | 2,191.00 | 1,600.00 | 1,823.38 |
| DPS- Common Stock Primary Issue | 30.00 | 30.00 | 30.00 | 30.00 |
| Provisionfor Income Taxes | 820.00 | 725.00 | 563.00 | 545.25 |
| period Type | - | - | - | - |
| Net Income Before Extra Items | 2,568.00 | 2,191.00 | 1,600.00 | 1,823.38 |
| Total Revenue | 10,560.00 | 9,360.00 | 7,845.00 | 7,767.51 |
| period Length | 12.00 | 12.00 | 12.00 | 12.00 |
| Revenue | 10,560.00 | 9,360.00 | 7,845.00 | 7,767.51 |
| Selling/ General/ Admin Expenses Total | 1,442.00 | 1,967.00 | 1,811.00 | 1,654.40 |
| Diluted Normalized EPS | 98.86 | 82.65 | 60.38 | 68.72 |
| Diluted EPS Excluding Extra Ord Items | 96.75 | 82.53 | 60.27 | 68.69 |
| Gain( Loss)on Saleof Assets | - | -4.00 | -4.00 | -1.13 |
| Research Development | - | 73.00 | 66.00 | 55.37 |
Divi's Laboratories Dividend Divi's Laboratories Bonus Divi's Laboratories News Divi's Laboratories AGM Divi's Laboratories Rights Divi's Laboratories Splits Divi's Laboratories Board Meetings Divi's Laboratories Key Metrics Divi's Laboratories Shareholdings Divi's Laboratories Balance Sheet Divi's Laboratories Cashflow Divi's Laboratories Q1 Results Divi's Laboratories Q2 Results Divi's Laboratories Q3 Results Divi's Laboratories Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.